1 / 6

Synthetic Biology Market Size, Share, Analysis Report, 2024 | Hexa Research

Synthetic biology market is expected to grow over the forecast period owing to the increasing uses of environmental applications such as biodegradation, contaminants, detection of environmental pathogens, distinct chemicals immobilization, and bio-transformation

Carrol
Download Presentation

Synthetic Biology Market Size, Share, Analysis Report, 2024 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Synthetic Biology Market Research Report - Global Industry Analysis, Size and Forecast to 2024 | Hexa Research “Synthetic biology market is expected to grow over the forecast period owing to the increasing uses of environmental applications such as biodegradation, contaminants, detection of environmental pathogens, distinct chemicals immobilization, and bio- transformation.” The Global Synthetic Biology Market is fueled by extensive research in DNA sequencing and rising governmental support. The growing importance of synthetic biology can be attributed to the demand for GMO (genetically modified) crops. Demand for biofuels and progress in molecular biology have had a positive impact on the global industry. Other drivers are high incidence of diabetes, the problem of obesity, growing geriatric population, and improved healthcare infrastructure. An amalgam of engineering and biology, synthetic biology involves the designing & development of biological devices that are employed in varied applications. It is an umbrella term that also includes aspects, like the remodeling of existing biological parts and the introduction of innovative biological-based devices & parts. Commercially, the industry is in the nascent stage. Costs of data generation have plummeted radically because of affordability of DNA sequencing. Synthetic biology has not only reduced the costs of DNA sequencing but has also contributed significantly to green energy. Browse Details of Report@ https://www.hexaresearch.com/research-report/synthetic-biology-industry Follow Us:

  2. Your Catalyst To a Lucrative Business The worldwide synthetic biology market is categorized on the basis of products, applications, technology, and geographies. Based on products, the industry is bifurcated into enabling products and core products. Enabling products is further divided into oligonucleotide synthesis and DNA synthesis. Core products are synthetic DNA, synthetic genes, synthetic cells, chassis organisms, and Xeno nucleic acid (XNA). Owing to in-depth R&D and extensive commercialization, the synthetic DNA segment dominated the overall industry in 2013. As per applications, the segments are healthcare, agriculture, bio-fuels, chemicals, and others. “Others” includes energy & environment, biosecurity, and R&D. Healthcare applications held the largest share in the global industry in 2013. Factors that fuel this segment are high production of nutraceuticals for supplements, newer therapies, vitamins, regenerative medicine, and for reprogramming stem cells. Technology-wise, the synthetic biology market is categorized into biological components, genome engineering, integrated systems, DNA sequencing, and bioinformatics. Genome engineering generated highest revenues for the global industry in 2013. Considerable progress in this field has reaped substantial market returns. Geographical segments of the overall synthetic biology market are Asia Pacific, North America, Europe, and RoW (Rest of the World). Due to a strong technological base, inclination towards in-depth R&D activities, and favorable governmental initiatives, North America dominates the worldwide market. Widespread awareness among patients is another vital driver in the region. However, due to surging healthcare spending and consciousness about hospital acquired infections, China and India can exhibit positive growth trends. This may stand to benefit the entire Asia Pacific region over the forecast period (2016 to 2024). Key companies operating in the worldwide market are Bioneer Corporation, Cobalt Technologies, Evolva SA, Gene Script Corporation, and Exxon Mobil Corporation. Synthetic biology is increasingly being used by scientists to develop genetic circuits that can be planted in cells for the production of useful molecules & drugs. However, the genetic components may interfere with one another because of complexities in the genetic circuits. Researchers at MIT have developed ways in which these circuits can be separated in each synthetic cell. Interactions between these cells can also be controlled; which in turn enables the circuits to be combined at certain times. The synthetic cells in question are not living cells but contain enough cellular machinery to produce proteins and read DNA. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of Synthetic Biology Market Chapter 1. Executive Summary 1.1. Synthetic biology - Industry Summary & Critical Success Factors (CSFs) Chapter 2. Synthetic biology Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Synthetic biology market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Synthetic biology- Company Market Share Analysis, 2013 2.7. Synthetic biology market PESTEL Analysis, 2013 Chapter 3. Synthetic biology Product Outlook 3.1. Core products 3.1.1. Global core products demand , 2016 - 2024 (USD Million) 3.1.1.1. Global Synthetic genes demand , 2016 - 2024 (USD Million) 3.1.1.2. Global Synthetic DNA demand , 2016 - 2024 (USD Million) 3.1.1.3. Global Synthetic cells demand, 2016 - 2024 (USD Million) 3.1.1.4. Global Chassis organisms demand, 2016 - 2024 (USD Million) 3.1.1.5. Global XNA (xeno nucleic acid) demand , 2016 - 2024 (USD Million) 3.2. Enabling products 3.2.1. Global enabling products demand , 2016 - 2024 (USD Million) 3.2.1.1. Global oligonucleotide synthesis demand, 2016 - 2024 (USD Million) 3.2.1.2. Global DNA synthesis demand, 2016 - 2024 (USD Million) Chapter 4. Synthetic biology Application Outlook 4.1. Agriculture 4.1.1. Agriculture demand, 2016 - 2024 (USD Million) 4.2. Chemicals(excluding bio-fuels) 4.2.1. Chemicals(excluding bio-fuels) demand, 2016 - 2024 (USD Million) 4.3. Bio-fuels 4.3.1. Bio-fuels demand, 2016 - 2024 (USD Million) Follow Us:

  4. Your Catalyst To a Lucrative Business 4.4. Healthcare 4.4.1. Healthcare demand, 2016 - 2024 (USD Million) 4.5. Others (R&D, biosecurity, energy and environment) 4.5.1. Others (R&D, biosecurity, energy and environment) demand, 2016 - 2024 (USD Million) Chapter 5. Synthetic biology Technology Outlook 5.1. DNA sequencing 5.1.1. Global DNA Sequencing demand, 2016 - 2024 (USD Million) 5.2. Genome engineering 5.2.1. Global genome engineering demand, 2016 - 2024 (USD Million) 5.3. Biological components 5.3.1. Global biological components demand, 2016 - 2024 (USD Million) 5.4. Integrated Systems and Bioinformatics 5.4.1. Global integrated systems and bioinformatics demand, 2016 - 2024 (USD Million) Chapter 6. Synthetic biology Regional Outlook 6.1. North America 6.1.1. North America synthetic biology revenue by product, 2016 - 2024 (USD Million) 6.1.2. North America synthetic biology revenue by application, 2016 - 2024 (USD Million) 6.1.3. North America synthetic biology revenue by technology, 2016 - 2024 (USD Million) 6.2. Europe 6.2.1. Europe synthetic biology revenue by product, 2016 - 2024 (USD Million) 6.2.2. Europe synthetic biology revenue by application, 2016 - 2024 (USD Million) 6.2.3. Europe synthetic biology revenue by technology, 2016 - 2024 (USD Million) 6.3. Asia Pacific 6.3.1. Asia Pacific synthetic biology revenue by product, 2016 - 2024 (USD Million) 6.3.2. Asia Pacific synthetic biology revenue by product application, 2016 - 2024 (USD Million) 6.3.3. Asia Pacific synthetic biology revenue by product technology, 2016 - 2024 (USD Million) 6.4. RoW 6.4.1. RoW synthetic biology revenue by product, 2016 - 2024 (USD Million) 6.4.2. RoW synthetic biology revenue by product application, 2016 - 2024 (USD Million) 6.4.3. RoW synthetic biology revenue by product technology, 2016 - 2024 (USD Million) Companies analyzed in competitive landscape Amyris Inc.. Agrivida Inc. Follow Us:

  5. Your Catalyst To a Lucrative Business Algenol Biofuels Inc. Bayer AG ATG:biosynthetics GmbH CBC Comprehensive Biomarker Center GmbH Bioneer Corporation Bristol-Myers Squibb Biosearch Technologies Inc. Gene Script Corporation GeneWorks Pty Ltd. Ginkgo Bioworks Exxon Mobil Corporation Evolva SA DuPont Inc. Cobalt Technologies New England Biolabs, Inc. Follow Us:

  6. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us:

More Related